Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Rejection of Kidney Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Microdose Study of Melphalan, Bortezomib and Dexamethasone
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.
- Status
- UNKNOWN
- Phase
- PHASE2
Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2